Normal view MARC view ISBD view

[Thromboxane A2 antagonistic effect of antiangina drugs, with special reference to trapidil and trapidil derivatives]. [electronic resource]

By:

Mentz, P

Contributor(s):

Producer: 19880314Description: 613-6 p. digitalISSN:

0031-7144

Subject(s):

In: Die Pharmazie vol. 42

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: English Abstract; Journal Article

There are no comments on this title.

to post a comment.

Back to results

20421 Integrin αvβ3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy.
by Xie, Huan
20422 Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy.
by Klaver, Yvonne L B
20423 [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
by Shi, Yan
20424 Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge.
by Bhagwandin, Shanel B
20425 Accuracy of malignant hyperthermia diagnoses in hospital discharge records.
by Pinyavat, Teeda
20426 Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.
by Bakrin, N
20427 Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
by Lord, A C
20428 Safety and quality outcomes in peritoneal surface malignancy patients: developing a national center for excellence in Colombia.
by Arias, Fernando
20429 Cytoreductive surgery under aminolevulinic acid-mediated photodynamic diagnosis plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from ovarian cancer and primary peritoneal carcinoma: results of a phase I trial.
by Liu, Yang
20430 Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome.
by Ihemelandu, Chukwuemeka
20431 Early-life febrile seizures worsen adult phenotypes in Scn1a mutants.
by Dutton, Stacey B B
20432 Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?
by Honoré, C
20433 Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
by Lumbroso-Le Rouic, L
20434 Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
by Muñoz-Casares, F C
20435 Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database.
by Byrne, Raphael M
20436 Host-Guest Polypyrrole Nanocomplex for Three-Stimuli-Responsive Drug Delivery and Imaging-Guided Chemo-Photothermal Synergetic Therapy of Refractory Thyroid Cancer.
by Ma, Xiaotu
20437 Conflicting Data on the Incidence of Leukopenia and Neutropenia After Heated Intraperitoneal Chemotherapy with Mitomycin C.
by Feferman, Yael
20438 Dual-Responsive Carbon Dot for pH/Redox-Triggered Fluorescence Imaging with Controllable Photothermal Ablation Therapy of Cancer.
by Choi, Cheong A
20439 Conservative therapy for chalazia: is it really effective?
by Wu, Albert Y
20440 Construction of small-sized superparamagnetic Janus nanoparticles and their application in cancer combined chemotherapy and magnetic hyperthermia.
by Xie, Liqin